[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Imaging in Oncology: Initial Staging and Evaluation of Cancer Therapy
Open Access
- 26 January 2013
- journal article
- review article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 22 (5) , 427-437
Abstract
Positron emission tomography (PET) with [18F]fluoro-2-deoxy-D-glucose (FDG) has proven to be a valuable diagnostic modality in various diseases. Its accuracy has been improved with the hybrid PET/computed tomography (CT) technique because of precise anatomic location of areas of abnormal FDG accumulation. This integrated PET/CT modality has been widely adopted, particularly in oncology. This paper reviews the role of FDG-PET/CT imaging in breast cancer, non-small-cell lung cancer, colorectal cancer, head and neck cancer as well as lymphoma on the basis of recent key articles. Special attention is paid to preoperative diagnostic workup, evaluation of treatment response and survival prognosis. Experience from specialized centers indicates that there is strong evidence for the clinical effectiveness of FDG-PET/CT in staging, restaging and the prediction of response to therapy in the above-mentioned malignancies. It is concluded that this imaging modality contributes considerably to improved patient management and paves the way to personalize cancer treatment in a cost-effective way.Keywords
This publication has 72 references indexed in Scilit:
- The Use of Multiple Time Point Dynamic Positron Emission Tomography/Computed Tomography in Patients With Oral/Head and Neck Cancer Does Not Predictably Identify Metastatic Cervical Lymph NodesJournal of Oral and Maxillofacial Surgery, 2013
- Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.2011
- Usefulness of Interim FDG-PET After Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Sequential Induction Chemotherapy Followed by Concurrent ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapyHead & Neck, 2011
- 18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin LymphomaJournal of Nuclear Medicine, 2010
- Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapyAnnals of Oncology, 2010
- Positron Emission Tomography in Staging Early Lung CancerAnnals of Internal Medicine, 2009
- Preoperative Staging of Lung Cancer with Combined PET–CTNew England Journal of Medicine, 2009
- Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007